Pfizer, Inc.

235 East 42nd Street,
New York, New York 10017
United States,
(212) 733-2323

Pfizer Inc. is a research-based, global biopharmaceutical company. Pfizer applies science and global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. The Company's global portfolio includes medicines, vaccines and medical devices, as well as many of the world’s best-known consumer healthcare products. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. The majority of Pfizer's revenues come from the manufacture and sale of biopharmaceutical products. Pfizer was established in 1849 and is based in New York City.

M&A Summary

Buy vs Sell

Year ≤ '13 '14 '15 '16 '17 '18 T
Buy (2.0/yr) # 20 2 3 5 - - 30
vol $223.3B $1.0B $17.0B $19.8B $261.0B
Sell (0.4/yr) # 10 - 1 1 - - 12
vol $35.5B $1.0B $36.5B

Top M&A Advisors

Financial Deals
Sign-up to View
Sign-up to View
Sign-up to View
Legal Deals
Sign-up to View
Sign-up to View
Sign-up to View

Deal Values

> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Warner-Lambert Company LLC
$90.2B (2000-02-08)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Pfizer Consumer Healthcare GmbH
$16.6B (2006-06-26)

According to our data here at Mergr, Pfizer has acquired 34 companies, including 10 in the last 5 years. A total of 12 acquisitions came from private equity firms. It has also divested 12 assets.

Pfizer’s largest acquisition to date was in 2000, when it acquired Warner-Lambert Company for $90.2B. It’s largest disclosed sale occurred in 2006, when it sold Pfizer Consumer Healthcare to Johnson & Johnson for $16.6B. Pfizer has acquired in 9 different US states, and 7 countries. The Company’s most targeted sectors include life science (87%) and consumer products (7%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 410 life science companies that have made at least 1 acquisition, 15 have acquired at least 5 companies, and 2 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 29 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 5 platform acquisitions.

Join Mergr and gain access to Pfizer’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.

What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 3.4K Private Equity Firms
  • 119K M&A Transactions
  • 129K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 35K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.